In response to COVID-19 and social distancing guidelines, healthcare services have evolved. Telehealth has been a part of this change and many services have introduced virtual telephone clinics. The HSE recently approved a video conferencing tool, 'Attend Anywhere', and although available it is not widely used. We have received positive feedback from patients, but only a few studies provide information on patient and clinician satisfaction of virtual consultations. We aim to validate this by assessing preferences towards virtual telephone and video consultations. 50 patients from the breast care clinic were included. Exclusion criteria were any new or symptomatic patients or those with a physical/intellectual incapacity. A questionnaire with Likert scales was used to assess patient and clinician attitude towards 'phone' (PC) or 'video' consultations (VC). The majority of patients (64%) requested a PC rather than a VC (36%). More patients used technology regularly in the VC group (88%) than the PC group (69%), and 94% of VC patients had experience with video calls (47% PC). VC patients felt safe using 'Attend Anywhere' (94%), said it was 'more personal' than a phone call (72%) but preferred face-to-face for future consultations as they 'liked the reassurance of a physical exam' (78% VC; 59% PC). All clinicians felt the lack of examination in virtual clinics impacts the doctor-patient relationship and would prefer face-to-face consultations where possible. Our findings demonstrate positive attitudes towards virtual clinics, however face-to-face appointments are preferred by both groups. We will repeat this survey following COVID-19 restrictions to determine if attitudes change.
P148. Virtual phone call or video consultations: Patient and clinician preference during COVID-19
Issue date 2021 May.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
